findmyKOL

Mariko Ishimori, MD

Basic profile

Cedars-Sinai Medical Center

ORCIDNone on fileNPI↗
✓ Full record
RegionLos Angeles, CA · WestSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH funding2007–2013Why? →

Mariko Ishimori is a Rheumatology/Immunology physician affiliated with Cedars-Sinai Medical Center. OpenAlex indexes 126 publications with 6,700 citations (h-index 25).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
126publications

Distinct works indexed by OpenAlex.

6,700citations

Total citations across indexed works.

25h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2NIH grants · 2007–2013

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

8700 Beverly Blvd.
Los Angeles, CA 900481865

Telephone

310-423-2170

Registry record last updated 6 Aug 2014.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    67.7%
    TNF inhibitor27.9%
    Enbrel Sureclick41%Humira(Cf) Pen18%Humira Pen15%Humira9%Humira(Cf)9%Enbrel Mini8%
    Part D<11 patients
    Folate Analog Metabolic Inhibitor10.4%
    Methotrexate100%
    Part D≥14 patients

    + 6 more classes in this area

  • Antiparasitic

    12.6%
    Antimalarial12.6%
    Hydroxychloroquine Sulfate100%
    Part D≥19 patients
  • Nervous system

    9.9%
    Gabapentinoids5.5%
    Gabapentin100%
    Part D<11 patients
    Nonsteroidal Anti-inflammatory Drug2.4%
    Meloxicam100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 2007–2013 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”